Healthcare stocks hold up as Lilly’s $3.5 billion plant plan hits tape; biotech bruised
New York, Jan 31, 2026, 13:49 EST — Market closed. Healthcare shares ended Friday stronger than the wider market following Eli Lilly’s announcement of a $3.5 billion manufacturing facility in Pennsylvania dedicated to injectable weight-loss drugs. CEO David Ricks described the new plant as “really state of the art manufacturing to last many decades to come” during a press briefing.…